Zhejiang Gongdong Medical Technology Co Ltd (605369) — Capital Reinvestment Ratio
Zhejiang Gongdong Medical Technology Co Ltd (605369) has a Capital Reinvestment Ratio of 0.44x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥59.82 Million) in capital expenditures (CN¥26.32 Million). See Zhejiang Gongdong Medical Technology Co balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Gongdong Medical Technology Co Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Zhejiang Gongdong Medical Technology Co Ltd's Capital Reinvestment Ratio across 10 annual periods. Check how aggressively does Zhejiang Gongdong Medical Technology Co reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhejiang Gongdong Medical Technology Co Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Gongdong Medical Technology Co Ltd from 2016 to 2025. For live market cap and broader valuation context, see market cap of Zhejiang Gongdong Medical Technology Co .
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.44x | CN¥253.96 Million | CN¥111.60 Million | ▼ -15.6% |
| 2024 | 0.52x | CN¥210.38 Million | CN¥109.61 Million | ▼ -20.7% |
| 2023 | 0.66x | CN¥185.39 Million | CN¥121.82 Million | ▲ +7.9% |
| 2022 | 0.61x | CN¥282.75 Million | CN¥172.18 Million | ▼ -17.6% |
| 2021 | 0.74x | CN¥372.99 Million | CN¥275.56 Million | ▲ +64.8% |
| 2020 | 0.45x | CN¥242.18 Million | CN¥108.57 Million | ▼ -46.4% |
| 2019 | 0.84x | CN¥122.33 Million | CN¥102.30 Million | ▲ +138.8% |
| 2018 | 0.35x | CN¥102.42 Million | CN¥35.87 Million | ▲ +139.3% |
| 2017 | 0.15x | CN¥85.54 Million | CN¥12.52 Million | ▲ +14.3% |
| 2016 | 0.13x | CN¥86.12 Million | CN¥11.03 Million | — |